Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Gastrointestinal Neoplasms × nilotinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Gastrointestinal Stromal Tumors 1 Gastrointestinal Neoplasms 1 Colonic Neoplasms 1

Interventions

nilotinib 1 Thoracoscopy 1 Thoracic Surgery, Video-Assisted 1 Quality of Life 1 Oxaliplatin 1 Nivolumab 1 Leucovorin 1 Interviews as Topic 1 Fluorouracil 1 Blood Specimen Collection 1 Anterior Temporal Lobectomy 1 AMG 337 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01270893 2012-08-02

Tasigna Neoadjuvant Gastrointestinal Stromal Tumor (GIST)

M.D. Anderson Cancer Center

Phase 2 Withdrawn

GastrointestinalSarcoma

Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡